Literature DB >> 20373868

Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer.

Daniel D Buchanan1, Aedan Roberts, Michael D Walsh, Susan Parry, Joanne P Young.   

Abstract

Colorectal cancer (CRC) develops within precursor lesions in the single-celled epithelial lining of the gut. The two most common epithelial lesions are the adenoma and the serrated polyp. CRC is also one of the most familial of the common cancers, and just as there are syndromes associated with increased risk of CRC arising in adenomas, there are also syndromes with increased CRC risk associated with serrated polyps. In this article, we describe the features of such a syndrome, familial serrated neoplasia, which distinguish it from the well-characterized condition Lynch syndrome (or hereditary nonpolyposis CRC), and show that the molecular pathology of tumors forms the basis for this distinction. Lynch syndrome CRC arises almost exclusively within adenomatous precursor lesions, in contrast with familial serrated neoplasia where at least half of the cancers develop in serrated polyps. Finally, rare families exist in which both conditions segregate independently, producing a difficult diagnostic picture.

Entities:  

Mesh:

Year:  2010        PMID: 20373868      PMCID: PMC2896690          DOI: 10.2217/fon.10.16

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  72 in total

1.  Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome.

Authors:  P Jeevaratnam; D S Cottier; P J Browett; N S Van De Water; V Pokos; J R Jass
Journal:  J Pathol       Date:  1996-05       Impact factor: 7.996

2.  A case of metaplastic polyposis of the colon associated with focal adenomatous change and metachronous adenocarcinomas.

Authors:  B G McCann
Journal:  Histopathology       Date:  1988-12       Impact factor: 5.087

Review 3.  Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Authors:  Jeremy R Jass
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

Review 4.  Hyperplastic-adenomatous polyposis syndrome.

Authors:  R J Place; C L Simmang
Journal:  J Am Coll Surg       Date:  1999-05       Impact factor: 6.113

5.  Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.

Authors:  Michael J O'Brien; Shi Yang; Charline Mack; Huihong Xu; Christopher S Huang; Elizabeth Mulcahy; Mark Amorosino; Francis A Farraye
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

6.  Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study.

Authors:  P Lage; M Cravo; R Sousa; P Chaves; M Salazar; R Fonseca; I Claro; A Suspiro; P Rodrigues; H Raposo; P Fidalgo; C Nobre-Leitão
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

7.  Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype.

Authors:  Dallas R English; Joanne P Young; Julie A Simpson; Mark A Jenkins; Melissa C Southey; Michael D Walsh; Daniel D Buchanan; Melissa A Barker; Andrew M Haydon; Simon G Royce; Aedan Roberts; Susan Parry; John L Hopper; Jeremy J Jass; Graham G Giles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

8.  Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis.

Authors:  P Minoo; K Baker; R Goswami; G Chong; W D Foulkes; A R Ruszkiewicz; M Barker; D Buchanan; J Young; J R Jass
Journal:  Gut       Date:  2006-02-09       Impact factor: 23.059

9.  Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps.

Authors:  Martha J Shrubsole; Huiyun Wu; Reid M Ness; Yu Shyr; Walter E Smalley; Wei Zheng
Journal:  Am J Epidemiol       Date:  2008-02-27       Impact factor: 4.897

10.  BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients.

Authors:  Pei Woon Ang; Wei Qi Li; Richie Soong; Barry Iacopetta
Journal:  Cancer Lett       Date:  2008-09-07       Impact factor: 8.679

View more
  3 in total

1.  Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis.

Authors:  Christophe Rosty; Michael D Walsh; Rhiannon J Walters; Mark Clendenning; Sally-Ann Pearson; Mark A Jenkins; Aung Ko Win; John L Hopper; Kevin Sweet; Wendy L Frankel; Melyssa Aronson; Steve Gallinger; Jack Goldblatt; Kathy Tucker; Sian Greening; Michael R Gattas; Sonja Woodall; Julie Arnold; Neal I Walker; Susan Parry; Joanne P Young; Daniel D Buchanan
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

2.  Serrated polyposis: an enigmatic model of colorectal cancer predisposition.

Authors:  Christophe Rosty; Susan Parry; Joanne P Young
Journal:  Patholog Res Int       Date:  2011-05-30

3.  Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).

Authors:  Aedan Roberts; Derek Nancarrow; Mark Clendenning; Daniel D Buchanan; Mark A Jenkins; David Duggan; Darin Taverna; Diane McKeone; Rhiannon Walters; Michael D Walsh; Bruce W Young; Jeremy R Jass; Christophe Rosty; Michael Gattas; Elise Pelzer; John L Hopper; Jack Goldblatt; Jill George; Graeme K Suthers; Kerry Phillips; Susan Parry; Sonja Woodall; Julie Arnold; Kathy Tucker; Amanda Muir; Musa Drini; Finlay Macrae; Polly Newcomb; John D Potter; Erika Pavluk; Annika Lindblom; Joanne P Young
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.